Výsledky vyhledávání - "Schejbalová, M"

Genetic analysis of lung cancer and the germline impact on somatic mutation burden

Publikováno v: Gabriel, A A G, Atkins, J R, Penha, R C C, Smith Byrne, K, Kar, S, McKay, J D & et, A 2022, ' Genetic analysis of lung cancer and the germline impact on somatic mutation burden ', Journal of the National Cancer Institute, vol. 114, no. 8, pp. 1159-1166 . https://doi.org/10.1093/jnci/djac087
JNCI: Journal of the National Cancer Institute
JNCI: Journal of the National Cancer Institute, 2022, 114 (8), pp.1159-1166. ⟨10.1093/jnci/djac087⟩

Background Germline genetic variation contributes to lung cancer (LC) susceptibility. Previous genome-wide association studies (GWAS) have implicated susceptibility loci involved in smoking behaviors and DNA repair genes, but further work is required

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9568c690878bbd01ed4e016717346c0
https://research-information.bris.ac.uk/ws/files/327769434/Full_text_PDF_final_published_version_.pdf

Zobrazit plný text záznamu

Akademický článek

Genetic Analysis of Lung Cancer and the Germline Impact on Somatic Mutation Burden.

Autor: Gabriel AAG; Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France., Atkins JR; Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France., Penha RCC; Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France., Smith-Byrne K; Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France.; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, England., Gaborieau V; Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France., Voegele C; Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France., Abedi-Ardekani B; Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France., Milojevic M; Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France., Olaso R; Université Paris-Saclay, The French Alternative Energies and Atomic Energy Commission (CEA), Centre National de Recherche en Génomique Humaine (CNRGH), Evry, France., Meyer V; Université Paris-Saclay, The French Alternative Energies and Atomic Energy Commission (CEA), Centre National de Recherche en Génomique Humaine (CNRGH), Evry, France., Boland A; Université Paris-Saclay, The French Alternative Energies and Atomic Energy Commission (CEA), Centre National de Recherche en Génomique Humaine (CNRGH), Evry, France., Deleuze JF; Université Paris-Saclay, The French Alternative Energies and Atomic Energy Commission (CEA), Centre National de Recherche en Génomique Humaine (CNRGH), Evry, France., Zaridze D; Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation., Mukeriya A; Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation., Swiatkowska B; Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Lodz, Poland., Janout V; Faculty of Medicine, Palacky University, Olomouc, Czech Republic., Schejbalová M; First Faculty of Medicine, Charles University, Prague, Czech Republic., Mates D; National Institute of Public Health, Bucharest, Romania., Stojšić J; Department of Thoracic Pathology, Service of Pathology, University Clinical Centre of Serbia, Belgrade, Serbia., Ognjanovic M; International Organisation for Cancer Prevention and Research, Belgrade, Serbia., Witte JS; Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, USA., Rashkin SR; Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, USA.; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA., Kachuri L; Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, USA., Hung RJ; Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Canada., Kar S; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Brennan P; Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France., Sertier AS; Fondation Synergie Lyon Cancer, Plateforme de bioinformatique Gilles Thomas, Lyon, France., Ferrari A; Fondation Synergie Lyon Cancer, Plateforme de bioinformatique Gilles Thomas, Lyon, France., Viari A; Fondation Synergie Lyon Cancer, Plateforme de bioinformatique Gilles Thomas, Lyon, France.; Inria Centre de Recherche Grenoble Rhone-Alpes, Grenoble, France., Johansson M; Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France., Amos CI; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, USA., Foll M; Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France., McKay JD; Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2022 Aug 08; Vol. 114 (8), pp. 1159-1166.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání